• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组成型激活的c-kit突变基因在IC-2小鼠白细胞介素-3依赖性肥大细胞系中的转化和诱导分化潜能。

Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.

作者信息

Hashimoto K, Tsujimura T, Moriyama Y, Yamatodani A, Kimura M, Tohya K, Morimoto M, Kitayama H, Kanakura Y, Kitamura Y

机构信息

Department of Pathology, Faculty of Medicine, Osaka University, Suita, Japan.

出版信息

Am J Pathol. 1996 Jan;148(1):189-200.

PMID:8546206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861586/
Abstract

Two mutations of c-kit receptor tyrosine kinase (KIT), valine-559 to glycine (G559) and aspartic acid-814 to valine (V814), resulted in its constitutive activation. To examine the transforming and differentiation-inducing potential of the mutant KIT, we used the murine interleukin-3-dependent IC-2 mast cell line as a transfectant. The IC-2 cells contained few basophilic granules and did not express KIT on the surface. The KITG559 or KITV814 gene was introduced into IC-2 cells using a retroviral vector. KITG559 and KITV814 expressed in IC-2 cells were constitutively phosphorylated on tyrosine and demonstrated kinase activity in the absence of stem cell factor, which is a ligand for KIT. IC-2 cells expressing either KITG559 or KITV814 (IC-2G559 or IC-2V814 cells) showed factor-independent growth in suspension culture and produced tumors in nude athymic mice. In addition, IC-2G559 and IC-2V814 cells showed a more mature phenotype compared with the phenotype of the original IC-2 cells, especially after transplantation into nude mice. The number of basophilic granules and the content of histamine increased remarkably. KITG559 and KITV814 also influenced the transcriptional phenotype of mouse mast cell proteases (MMCP) in IC-2 cells. The expression of MMCP-2, MMCP-4, and MMCP-6 was much greater in IC-2G559 and IC-2V814 cells than in the original IC-2 cells. The results indicated that constitutively activated KIT had not only oncogenic activity but also differentiation-inducing activity in mast cells.

摘要

c-kit受体酪氨酸激酶(KIT)的两种突变,缬氨酸559突变为甘氨酸(G559)和天冬氨酸814突变为缬氨酸(V814),导致其组成性激活。为了检测突变型KIT的转化和诱导分化潜能,我们使用了依赖小鼠白细胞介素-3的IC-2肥大细胞系作为转染细胞。IC-2细胞含有的嗜碱性颗粒很少,且表面不表达KIT。使用逆转录病毒载体将KITG559或KITV814基因导入IC-2细胞。在IC-2细胞中表达的KITG559和KITV814在酪氨酸上组成性磷酸化,并且在没有作为KIT配体的干细胞因子的情况下表现出激酶活性。表达KITG559或KITV814的IC-2细胞(IC-2G559或IC-2V814细胞)在悬浮培养中表现出不依赖因子的生长,并在无胸腺裸鼠中产生肿瘤。此外,与原始IC-2细胞的表型相比,IC-2G559和IC-2V814细胞表现出更成熟的表型,尤其是在移植到裸鼠体内后。嗜碱性颗粒的数量和组胺的含量显著增加。KITG559和KITV814也影响IC-2细胞中小鼠肥大细胞蛋白酶(MMCP)的转录表型。MMCP-2、MMCP-4和MMCP-6在IC-2G559和IC-2V814细胞中的表达比在原始IC-2细胞中高得多。结果表明,组成性激活的KIT在肥大细胞中不仅具有致癌活性,还具有诱导分化活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/1c049b1cc8cd/amjpathol00037-0194-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/128731bec011/amjpathol00037-0191-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/2fd2429d440c/amjpathol00037-0192-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/8cebdd8c110b/amjpathol00037-0193-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/1c049b1cc8cd/amjpathol00037-0194-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/128731bec011/amjpathol00037-0191-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/2fd2429d440c/amjpathol00037-0192-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/8cebdd8c110b/amjpathol00037-0193-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6841/1861586/1c049b1cc8cd/amjpathol00037-0194-a.jpg

相似文献

1
Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.组成型激活的c-kit突变基因在IC-2小鼠白细胞介素-3依赖性肥大细胞系中的转化和诱导分化潜能。
Am J Pathol. 1996 Jan;148(1):189-200.
2
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.c-kit受体酪氨酸激酶的组成性激活突变赋予因子依赖性造血细胞系不依赖因子的生长和致瘤性。
Blood. 1995 Feb 1;85(3):790-8.
3
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.在人肥大细胞白血病细胞系中鉴定原癌基因c-kit编码序列中的突变,该突变导致c-kit产物的配体非依赖性激活。
J Clin Invest. 1993 Oct;92(4):1736-44. doi: 10.1172/JCI116761.
4
Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.磷脂酰肌醇3'-激酶是表达kit催化结构域突变体的肥大细胞生长所必需的。
Cancer Res. 2003 Aug 1;63(15):4412-9.
5
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.携带新型非配体依赖性激活型C-kit突变的急性髓系白血病母细胞在体内向肥大细胞的分化
Blood Cells Mol Dis. 1998 Jun;24(2):262-70. doi: 10.1006/bcmd.1998.0191.
6
A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells.c-kit催化结构域中的一个点突变可诱导肥大细胞生长因子非依赖性、致瘤性和分化。
Blood. 1996 Apr 15;87(8):3117-23.
7
Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.犬肥大细胞c-kit突变非依赖性肿瘤细胞增殖的鉴定
Vet Immunol Immunopathol. 2008 Nov 15;126(1-2):43-53. doi: 10.1016/j.vetimm.2008.06.014. Epub 2008 Jul 5.
8
The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.c-Kit/D816V突变消除了c-Kit两种同工型在信号转导和生物学反应上的差异。
Cell Signal. 2009 Mar;21(3):413-8. doi: 10.1016/j.cellsig.2008.11.008. Epub 2008 Nov 17.
9
Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells.Trp53缺陷可挽救Kit(W-v)小鼠的雄性生育缺陷,但对黑素细胞和肥大细胞的存活没有影响。
Dev Biol. 1999 Nov 1;215(1):78-90. doi: 10.1006/dbio.1999.9440.
10
STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity.STAT3激活是Asp(816)突变型c-Kit诱导肿瘤发生所必需的。
Oncogene. 2001 Jul 27;20(33):4528-36. doi: 10.1038/sj.onc.1204590.

引用本文的文献

1
A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization.KIT细胞外结构域中的一个点突变通过不依赖配体的自动二聚化促进肥大细胞的肿瘤发生。
Sci Rep. 2015 May 12;5:9775. doi: 10.1038/srep09775.
2
KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells.KIT GNNK 剪接变异体:在系统性肥大细胞中的表达及其对肥大细胞中 D816V 突变激活潜能的影响。
Exp Hematol. 2013 Oct;41(10):870-881.e2. doi: 10.1016/j.exphem.2013.05.005. Epub 2013 Jun 4.
3
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.

本文引用的文献

1
Deficient differentiation of mast cells in the skin of mi/mi mice. Usefulness of in situ hybridization for evaluation of mast cell phenotype.mi/mi小鼠皮肤中肥大细胞分化缺陷。原位杂交在评估肥大细胞表型中的应用。
Am J Pathol. 1993 Nov;143(5):1337-47.
2
Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases.白细胞介素-9对编码晚期表达的小鼠肥大细胞蛋白酶的14号染色体衍生转录本水平的诱导作用以及白细胞介素-3和白细胞介素-4对其的抑制作用。
J Immunol. 1993 Oct 15;151(8):4266-73.
3
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
SHP2 磷酸酶在 KIT 诱导的转化中的作用:鉴定 SHP2 作为涉及致癌性 KIT 的疾病中的可用药靶。
Blood. 2012 Sep 27;120(13):2669-78. doi: 10.1182/blood-2011-08-375873. Epub 2012 Jul 17.
4
Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease.细胞内酪氨酸在激活 KIT 诱导的骨髓增生性疾病中的作用。
Leukemia. 2012 Jul;26(7):1499-1506. doi: 10.1038/leu.2012.22. Epub 2012 Feb 2.
5
Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.活化 STAT5 在系统性肥大细胞增多症中肿瘤性肥大细胞中的表达:转化癌蛋白 KIT D816V 的亚细胞分布和作用。
Am J Pathol. 2009 Dec;175(6):2416-29. doi: 10.2353/ajpath.2009.080953. Epub 2009 Nov 5.
6
Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.遗传和药理学证据表明,在急性髓系白血病和系统性肥大细胞增多症中,PI3K的p85α调节亚基而非p85β调节亚基以及Rac2 GTP酶参与调控致癌性KIT诱导的细胞转化。
Blood. 2007 Sep 1;110(5):1612-20. doi: 10.1182/blood-2006-10-053058. Epub 2007 May 4.
7
Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.肥大细胞增多症患者骨髓中携带激活型试剂盒突变D816V的肥大细胞、T细胞和B细胞呈簇状出现的证明。
J Mol Diagn. 2004 Nov;6(4):335-42. doi: 10.1016/S1525-1578(10)60529-6.
8
Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.胃肠道间质瘤(GIST):实体瘤分子诊断与治疗的模型
Cancer Sci. 2003 Apr;94(4):315-20. doi: 10.1111/j.1349-7006.2003.tb01439.x.
9
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.对人肥大细胞系的两个变体进行功能和表型研究,这两个变体在c-kit原癌基因中有一组独特的突变。
Immunology. 2003 Jan;108(1):89-97. doi: 10.1046/j.1365-2567.2003.01559.x.
10
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.在人类肥大细胞增多症的不同临床形式中,c-KIT催化结构域存在激活型和显性失活型突变。
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1609-14. doi: 10.1073/pnas.96.4.1609.
在人肥大细胞白血病细胞系中鉴定原癌基因c-kit编码序列中的突变,该突变导致c-kit产物的配体非依赖性激活。
J Clin Invest. 1993 Oct;92(4):1736-44. doi: 10.1172/JCI116761.
4
Signalling by receptor tyrosine kinases.受体酪氨酸激酶信号传导
Annu Rev Biochem. 1993;62:453-81. doi: 10.1146/annurev.bi.62.070193.002321.
5
Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation.杂合子皮肤中的肥大细胞数量反映了c-kit突变的分子性质。
Blood. 1993 May 15;81(10):2530-8.
6
Reversible expansion of primate mast cell populations in vivo by stem cell factor.干细胞因子在体内对灵长类动物肥大细胞群体的可逆性扩增作用。
J Clin Invest. 1993 Jan;91(1):148-52. doi: 10.1172/JCI116164.
7
Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.天冬氨酸的替换导致大鼠肿瘤肥大细胞系RBL - 2H3中c - kit受体酪氨酸激酶的组成型激活。
Int Arch Allergy Immunol. 1995 Apr;106(4):377-85. doi: 10.1159/000236870.
8
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.c-kit受体酪氨酸激酶的组成性激活突变赋予因子依赖性造血细胞系不依赖因子的生长和致瘤性。
Blood. 1995 Feb 1;85(3):790-8.
9
Poor response of cultured mast cells derived from mi/mi mutant mice to nerve growth factor.
Blood. 1994 Nov 1;84(9):2977-83.
10
Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.由点突变产生的小鼠肥大细胞瘤细胞系P-815中c-kit受体酪氨酸激酶的非配体依赖性激活。
Blood. 1994 May 1;83(9):2619-26.